Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Guardian - US
The Guardian - US
Comment
Moira Donegan

The supreme court’s abortion pill ruling isn’t the end of a fight. It’s the beginning

An abortion rights protester holds signs reading 'Keep abortion legal' in front of the US supreme court building.
‘It is likely that the anti-choice lawyers bringing the suit will soon find plaintiffs with more plausible standing claims.’ Photograph: Patsy Lynch/Rex/Shutterstock

On Thursday, the US supreme court unanimously ruled that the Alliance for Hippocratic Medicine – a sock-puppet group of fanatically anti-choice doctors and busybodies – lacked standing to sue in the group’s challenge to the Food and Drug Administration’s approval of mifepristone, the drug that is now used in more than 60% of American abortions. The court’s decision may seem like the end of this battle. It’s only the beginning.

The lawsuit in question had originally emerged from Amarillo, Texas, in a federal court that has become a destination for anti-choice litigants because Matthew Kacsmaryk, a Trump appointee and the sole judge hearing federal civil cases in the district, is a militant anti-abortion activist. Kacsmaryk made news when he used to case as a pretext to issue a nationwide injunction revoking FDA approval of the drug. The fifth circuit court, a radically rightwing appeals panel which has jurisdiction over Texas and which has repeatedly sought to push the supreme court to new heights of anti-abortion extremism, upheld most of Kacsmaryk’s ruling, but limited the case to challenges that the FDA made in 2016 and 2021 to make mifepristone more easily available.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.